NCT02242825View on ClinicalTrials.gov

Study to Evaluate the Effect of Micardis® / MicardisPlus® on Metabolic Parameters in Patients With Essential Hypertension and Diabetes Mellitus

CompletedOBSERVATIONAL
Enrollment

8,148

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

October 31, 2006

Conditions
Hypertension
Interventions
DRUG

Micardis®

DRUG

MicardisPlus®

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02242825 - Study to Evaluate the Effect of Micardis® / MicardisPlus® on Metabolic Parameters in Patients With Essential Hypertension and Diabetes Mellitus | Biotech Hunter | Biotech Hunter